Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCAT| |AAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTG
End
99818049/99201586 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/2403233; hsa-mir-10b/Downstream/2107864;
Upstream sequence
GGAGAAGGGATTAGCTCTAGCCCAACTACAGACCATGCTTCCGGGACATCCTCCTGGTCTTGACAGTGGTGAAAATCTGGATGTCATGAATTCTGTGGCC
Downstream sequence
TGACTTCACCTGCCCTTGACTAAAGAGGGGGATtgaggaaaagaaaaagcaacttctgacagccaggaactggcctggaactctcaggccttggtgtttc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.